The STEP UP trial, published in The Lancet Diabetes & Endocrinology in September 2025, showed 18.7% average weight loss at 72 weeks compared to 15.6% at the standard 2.4 mg dose
It is co-formulated with an absorption enhancer (SNAC), which allows it to be taken orallybut under strict conditions, such as fasting and limited water intake. Clinical studies suggest that injectable semaglutide generally provides greater efficacy, particularly in terms of HbA1c reduction and weight loss. This is largely due to its higher and more consistent bioavailability
Almaguer Cantu V, Garza-Gonzlez MT, de la Rosa JR, Loredo-Medrano JA
Some reduce to partial breastfeeding
How to Mix HCG and Test: A Comprehensive Guide to Safe and Effective Protocols You've heard the whispers in locker rooms, seen the forum threads, and perhaps even had a conversation with your clinician about the powerful synergy between two compounds that can redefine a therapeutic protocol